GSK Egypt swings to loss in Q1-24
Cairo – Mubasher: GlaxoSmithKline (GSK Egypt) turned to a consolidated net loss of EGP 8.98 million in the first quarter (Q1) of 2024, versus a net profit of EGP 13.81 million in the corresponding quarter a year earlier. Consolidated net sales …